Clinical Trial: Berberol P for Mild-to-Moderate Hypercholesterolaemia

U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07789366) titled 'Berberol P for Mild-to-Moderate Hypercholesterolaemia' on Aug. 22.

Brief Summary: This randomized, controlled, multicentre clinical trial will evaluate the efficacy and safety of Berberol(R) P compared with Berberol(R) K in adults with mild-to-moderate hypercholesterolaemia.

A total of 255 participants will be randomized in a 1:1:1 ratio to receive Berberol(R) P 1 tablet daily, Berberol(R) P 2 tablets daily, or Berberol(R) K 1 tablet daily for 12 weeks. The study will primarily assess whether Berberol(R) P is non-inferior to Berberol(R) K in reducing low-density lipoprotein cholesterol (LDL-C). Changes in other lipid parameters, gl...